Norway Interventional Cardiology Devices Market Size & Outlook
- MedTech
- Cardiovascular Devices
- Interventional Cardiology Devices Market Outlook
- Cardiovascular Devices
Global Market
Related Markets
Ask a question about the interventional cardiology devices market
Norway interventional cardiology devices market highlights
- The Norway interventional cardiology devices market generated a revenue of USD 68.3 million in 2025 and is expected to reach USD 111.1 million by 2033.
- The Norway market is expected to grow at a CAGR of 6.5% from 2026 to 2033.
- In terms of segment, coronary stents was the largest revenue generating products in 2025.
- Intravascular Imaging Catheters and Pressure Guidewires is the most lucrative products segment registering the fastest growth during the forecast period.
Interventional cardiology devices market data book summary
| Market revenue in 2025 | USD 68.3 million |
| Market revenue in 2033 | USD 111.1 million |
| Growth rate | 6.5% (CAGR from 2026 to 2033) |
| Largest segment | Coronary stents |
| Fastest growing segment | Intravascular Imaging Catheters and Pressure Guidewires |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
Other key industry trends
- In terms of revenue, Norway accounted for 0.6% of the global interventional cardiology devices market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany interventional cardiology devices market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 1,183.5 million by 2033.
The reimbursement scenario for cardiovascular devices in Norway is regulated by the Norwegian Directorate of Health and the Norwegian Medicines Agency. The reimbursement process involves a thorough evaluation of the clinical and economic evidence for medical devices.
If a device is deemed effective and cost-effective, it is included in the Norwegian List of Reimbursable Medicines and Medical Devices (LEK), which determines their reimbursement rates. The regulatory framework for cardiovascular devices in Norway is governed by the Norwegian Medicines Agency.
The agency is responsible for ensuring the safety, efficacy, and quality of medical devices, including cardiovascular devices. The Medical Device Act and associated regulations provide the legal framework for the approval and monitoring of medical devices in Norway.
No credit card required*
Publish Date: Apr 15, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Interventional Cardiology Devices Market Scope
Interventional Cardiology Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Teleflex Inc | View profile | 14,500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | www.teleflex.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | www.bbraun.co.uk |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
| Biosensors | View profile | 1001-5000 | Singapore, Central Region, Singapore, Asia | biosensors.com |
Norway Interventional Cardiology Devices Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Interventional Cardiology Devices Market Outlook will help companies and investors design strategic landscapes.
Coronary Stents was the largest segment with a revenue share of 49.34% in 2025.
Horizon Databook has segmented the Norway interventional cardiology devices market based on coronary stents, ptca balloon catheters, intravascular imaging catheters and pressure guidewires, accessory devices covering the revenue growth of each sub-segment from 2021 to 2033.
The reimbursement scenario for cardiovascular devices in Norway is regulated by the Norwegian Directorate of Health and the Norwegian Medicines Agency. The reimbursement process involves a thorough evaluation of the clinical and economic evidence for medical devices.
If a device is deemed effective and cost-effective, it is included in the Norwegian List of Reimbursable Medicines and Medical Devices (LEK), which determines their reimbursement rates. The regulatory framework for cardiovascular devices in Norway is governed by the Norwegian Medicines Agency.
The agency is responsible for ensuring the safety, efficacy, and quality of medical devices, including cardiovascular devices. The Medical Device Act and associated regulations provide the legal framework for the approval and monitoring of medical devices in Norway.
- Norway Interventional Cardiology Devices Market Products Outlook (Revenue, USD Million , 2021-2033)
- Coronary Stents
- PTCA Balloon Catheters
- Intravascular Imaging Catheters and Pressure Guidewires
- Accessory Devices
- Norway Interventional Cardiology Devices Market Procedures Outlook (Revenue, USD Million , 2021-2033)
- Coronary Artery Disease (CAD)
- Acute Myocardial Infarction (AMI)
- Chronic Total Occlusion (CTO)
- Norway Interventional Cardiology Devices Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Cath Labs
- Ambulatory Surgical Centers (ASCs)
- Specialty Cardiac Centers
Reasons to subscribe to Interventional Cardiology Devices Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Interventional Cardiology Devices Market Outlook databook
- Our clientele includes a mix of Interventional Cardiology Devices Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway Interventional Cardiology Devices Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway Interventional Cardiology Devices Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Norway Interventional Cardiology Devices Market, 2021-2033 (US$M)
Norway interventional cardiology devices market statistics, by products, 2021-2033 (US$M)
